NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

J A Romashkova1, S S Makarov

  • 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, 27599-7280, USA.

Nature
|September 15, 1999
PubMed

Insights

Platelet-derived growth factor (PDGF) promotes cell survival by inhibiting apoptosis. This study reveals PDGF activates NF-kappaB via the Ras/PI(3)K/Akt/IKK pathway, linking survival signals to cell proliferation control.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Cell proliferation and transformation are closely tied to apoptosis, the programmed cell death pathway.
  • Platelet-derived growth factor (PDGF) is a key survival factor promoting cell proliferation but its anti-apoptotic mechanisms are not fully elucidated.
  • Understanding how survival signals regulate cell fate is crucial for cancer research.

Purpose of the Study:

  • To investigate the role of the transcription factor NF-kappaB in PDGF signaling.
  • To elucidate the molecular pathway mediating PDGF's anti-apoptotic effects.
  • To link growth factor signaling with the transcription machinery controlling cell fate.

Main Methods:

  • Investigated PDGF-induced activation of NF-kappaB.
  • Utilized Ras, phosphatidylinositol-3-kinase (PI(3)K), PKB/Akt, and IkappaB kinase (IKK) as key components in the signaling pathway.
  • Examined in vivo association of Akt with IKK upon PDGF stimulation.

Main Results:

  • Demonstrated NF-kappaB's critical role in PDGF signaling.
  • Identified NF-kappaB as a mediator of both proliferation (via c-myc) and anti-apoptotic signals.
  • Showed that PDGF activates NF-kappaB through a Ras/PI(3)K/Akt/IKK pathway.
  • Confirmed Akt's transient in vivo association with and activation of IKK following PDGF stimulation.

Conclusions:

  • Established a novel anti-apoptotic signaling pathway: Ras/PI(3)K/Akt/IKK/NF-kappaB.
  • Linked PDGF-mediated survival signals directly to the transcriptional machinery.
  • Provided new insights into the molecular mechanisms governing cell proliferation, survival, and the inhibition of apoptosis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...